MINDSAI CO., LTD. – Trademark Portfolio

Entity Type: 99

MINDSAI CO., LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MINDS. NAVI, CHEEU. FOREST, and MINDS. FORECAST.

3F, 155, Dogok-ro,

Gangnam-gu Seoul

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

MINDSAI CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (3 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

44
Medical Services (3 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does MINDSAI CO., LTD. have?

MINDSAI CO., LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does MINDSAI CO., LTD. file in?

MINDSAI CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 44 (Medical Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are MINDSAI CO., LTD.'s most well-known trademarks?

MINDSAI CO., LTD.'s registered trademark portfolio includes well-known marks such as MINDS. NAVI, CHEEU. FOREST, and MINDS. FORECAST. These are among 3 currently registered trademarks in the portfolio.

What is MINDSAI CO., LTD.'s trademark registration success rate?

MINDSAI CO., LTD. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.